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Background
IAVI is currently undertaking epidemiology studies and
phase I/II clinical trials of prophylactic HIV vaccines in
India and Africa. Accredited clinical trial laboratories,
established as a collaborative effort between in country
research organizations and IAVI now exist as a well recog-
nized laboratory network. Good Clinical Laboratory Prac-
tice (GCLP) implementation and laboratory
standardization is the key to success.
Methods
Laboratory Standardisation
The concept of a central Core Laboratory as a foundation
for standardization across clinical trial laboratory testing
sites has been successfully implemented for both immu-
nogenicity and safety testing. The IAVI Human Immunol-
ogy Laboratory (HIL) was established as a unique
partnership with Imperial College and Chelsea Westmin-
ster Healthcare NHS Trust, in London, England. The Clin-
ical Safety Testing Support Laboratory is contracted to
Contract Laboratory Services (CLS), Johannesburg, South
Africa. Both laboratories provide ongoing support for the
following: 1) Site assessment and development; 2) Equip-
ment/reagent supply; 3) Validation of assays, standardiza-
tion of Equipment/Reagents/Consumables; 4) Training;
5) SOP development; 6) GCLP compliance.
GCLP
GCLP guidelines define the standards expected from regu-
latory agencies for laboratory practice in clinical trials.
IAVI has led the field by introducing a system to facilitate
and ensure GCLP implementation and compliance.
Results
Through this partnership the IAVI Laboratory Support
Program has ensured that 9 Clinical Research Laborato-
ries; Pune and Chennai, India; Nairobi and Kilifi, Kenya,
Entebbe and Masaka, Uganda, Kigali, Rwanda and Johan-
nesburg and Cape Town, South Africa have received full
GCLP accreditation since implementation of the pro-
gramme in 2004. Four other African laboratories have
GCLP accreditation in progress.
Conclusion
The process of GCLP accreditation builds long lasting
capacity for clinical trial support in countries where HIV,
TB, Malaria and other vaccines are being tested and also
supports the infrastructure for state-of-the art infectious
disease research and intervention studies. Accreditation
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